Specielle situation - interessant for lange porteføljer
-
I min opsamling på nyheder faldt jeg over denne fra Oldschoolvalue.com. Som Jae Jun opstiller det så ser risk/reward interessant ud for en lang portefølje. Aktien er NuPathe Inc., som ikke havde penge til føre et migrænemiddel på markedet, men det havde Teva. De har lavet en speciel aftale, hvor der falder flere mønter af, hvis salget opnår bestemte mål.
http://www.oldschoolvalue.com/blog/special_situation/nupathe-path
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind